
Crosstree Capital Partners’ Medical Technology (“MedTech”) coverage is dedicated to providing advisory and transaction services to the medical device, medical equipment and supplies, and medical device components and manufacturing industries. This industry group comprises companies involved in the development and manufacturing of any product that is used for medical purposes on humans, having primarily a physical rather than chemical mode of action, including Class I, II and III devices as defined by the FDA. Such products range from tongue depressors to implantable neuro-modulation devices, and certain biological products are also included if they are used like a device rather than as a drug. Please note that, while certain diagnostic products such as imaging equipment or sensors represent an area of focus for Crosstree, this category is covered under Crosstree’s Diagnostics and Tools practice.